|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,696.00 GBX | +1.00% |
|
-2.59% | -0.74% |
| 22/01 | HSBC chair to join PM Starmer on China visit next week - Sky | AN |
| 22/01 | Daiichi and AstraZeneca's Enhertu wins sixth approval in China | AN |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 28.05x | 6.32x | 0.62x | 5.22x | 15.48x | 16.3x | 1.77% | 28TCr | ||
| 47.41x | 36.37x | 0.49x | 15.69x | 34.96x | 37.84x | 0.54% | 97TCr | ||
| 21.13x | 6.72x | 0.27x | 5.88x | 16.33x | 17.92x | 2.36% | 53TCr | ||
| 63.2x | 911.91x | 1.42x | 7.25x | 17.38x | 18.01x | 3% | 39TCr | ||
| 20.86x | 7.11x | 0.34x | 5.07x | 12.57x | 14.2x | 2.85% | 38TCr | ||
| 20.34x | 6.51x | 0.97x | 5.38x | 12.66x | 13.72x | 2.82% | 28TCr | ||
| 13.98x | 5.03x | 0.88x | 4.56x | 9.84x | 11.06x | 2.96% | 27TCr | ||
| 17.17x | 9.32x | 8.22x | 6.07x | 12.54x | 14.52x | 2.93% | 28TCr | ||
| 27.12x | 20.66x | 0.39x | 6.37x | 10.91x | 14.62x | 2.76% | 19TCr | ||
| 19.57x | 7.22x | 0.01x | 6.01x | 10.99x | 13.23x | 2.53% | 16TCr | ||
| 13.01x | 1.64x | 0.31x | 3.1x | 7.77x | 9.05x | 6.55% | 15TCr | ||
| 30.12x | 6.25x | -0.04x | 9.08x | 19.64x | 20.39x | -.--% | 12TCr | ||
| 14.08x | 5.58x | -0.07x | 3.04x | 9.08x | 9.61x | 4.48% | 11TCr | ||
| 11.89x | 1.24x | 0.26x | 2.5x | 8.15x | 8.99x | 5.16% | 11TCr | ||
| 13.34x | 5.03x | 0.12x | 2.66x | 7.69x | 9x | 3.59% | 9.77TCr | ||
| 32.26x | 7x | 3.03x | 10.38x | 20.38x | 21.77x | 3.02% | 8.73TCr | ||
| 44.54x | 6.49x | 1.33x | 10.76x | 35.45x | 37.09x | 0.47% | 5.67TCr | ||
| 42.05x | 1.16x | 0.56x | 2.62x | 9.79x | 27.7x | 3.98% | 5.02TCr | ||
| 188.14x | 1.32x | -1.73x | 1.64x | 7.87x | 14.04x | 0.25% | 5.1TCr | ||
| Average | 35.17x | 55.42x | 0.92x | 5.96x | 14.71x | 17.32x | 2.74% | 23.99TCr | |
| Weighted average by Cap. | 32.19x | 89.77x | 1.03x | 7.74x | 18.17x | 20.14x | 2.36% |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















